Ranbaxy/GSK Partnership Yields First Drug Candidate
This article was originally published in The Pink Sheet Daily
Executive Summary
Ranbaxy will develop a respiratory disease candidate through proof of concept under an expanded discovery agreement inked with GSK in February.